Generation of three induced pluripotent stem cell lines from patients with glycogen storage disease type III

Stem Cell Res. 2023 Oct:72:103214. doi: 10.1016/j.scr.2023.103214. Epub 2023 Sep 23.

Abstract

Glycogen storage disease type III (GSDIII) is an autosomal recessive disorder characterized by a deficiency of glycogen debranching enzyme (GDE) leading to cytosolic glycogen accumulation and inducing liver and muscle pathology. Skin fibroblasts from three GSDIII patients were reprogrammed into induced pluripotent stem cells (iPSCs) using non-integrated Sendai virus. All of the three lines exhibited normal morphology, expression of pluripotent markers, stable karyotype, potential of trilineage differentiation and absence of GDE expression, making them valuable tools for modeling GSDIII disease in vitro, studying pathological mechanisms and investigating potential treatments.

MeSH terms

  • Glycogen Debranching Enzyme System*
  • Glycogen Storage Disease Type III* / metabolism
  • Glycogen Storage Disease Type III* / pathology
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Liver / pathology
  • Muscles / metabolism
  • Muscles / pathology

Substances

  • Glycogen Debranching Enzyme System